Patent details

301011 Product Name: pegvaliase

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
301011
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP2152868
Status:
SPC granted but not yet in force
Application number:
301011
Procedural language:
Dutch
First Applicant Residence Country:
United States of America (US)

Marketing Authorization

Marketing Authorization Number:
EU/1/19/1362
Marketing Authorization Type:
EEA
Marketing Authorization Date:
08/05/2019
Marketing Authorization Country:
European Union (EU)

Dates

Filing date:
09/10/2019
First Marketing Authorization date:
08/05/2019
Grant date:
13/05/2020
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
11/10/2019
SPC/SPC Extension Expiration Date:
22/05/2033
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:

Applicant/holder

From:
09/10/2019
 
 

 

Name:
BioMarin Pharmaceutical Inc.
Address:
105 Digital Drive, NOVATO, CA 94949, United States of America (US)

Agent

Name:
ir. F.A. Geurts c.s.
From:
09/10/2019
Address:
Octrooibureau Vriesendorp & Gaade B.V. Koninginnegracht 19, 2514 AB, Den Haag, Netherlands (NL)
To:

Publication

Bulletin

1

Bulletin Heading:
SPC
Journal edition number:
20/20
Publication date:
13/05/2020
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

2

Bulletin Heading:
SPC
Journal edition number:
42/19
Publication date:
16/10/2019
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

Annual Fee

Annual Fee(s) Due Date:
31/05/2028
Annual Fee Number:
21
Annual Fee Amount:
1600 Euro
Last Annual Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Document Description Number of pages File Type
13/05/2020 Outgoing Correspondence Decision grant 1 PDF /2/5/6/0/7/0800470652/docs/301011_3_343847l504a.pdf
13/05/2020 SPC Documents Certificate SPC 1 PDF /2/5/6/0/7/0800470652/docs/301011_7_supplprotectioncertificate20200513123359762.pdf
09/03/2020 Incoming Correspondence Paper Accompanying letter incoming document 1 PDF /2/5/6/0/7/0800470652/docs/301011_1_incomingcorrespondencepaper20210308010022925.pdf
20/12/2019 Outgoing Correspondence Letter to applicant 1 PDF /2/5/6/0/7/0800470652/docs/301011_0_outgoingcorrespondence20191220012653513.pdf
14/10/2019 Outgoing Correspondence Confirmation receipt request 1 PDF /2/5/6/0/7/0800470652/docs/301011_4_303761l174.pdf
09/10/2019 SPC Documents Annex SPC 1 PDF /2/5/6/0/7/0800470652/docs/301011_2_supplprotectioncertificate20200609013031754.pdf
09/10/2019 Application Form First filed application form 4 PDF /2/5/6/0/7/0800470652/docs/301011_5_applicationform20191011021141953.pdf
09/10/2019 SPC Documents Summary of the characteristics of the product 24 PDF /2/5/6/0/7/0800470652/docs/301011_6_supplprotectioncertificate20191011021142160.pdf
09/10/2019 SPC Documents Marketing Authorization SPC 3 PDF /2/5/6/0/7/0800470652/docs/301011_8_supplprotectioncertificate20191011021142086.pdf